Li Cheng

Dr. Cheng was Associate Director of Cytogenetics at Genoptix for three years prior to the NeoGenomics acquisition. Dr. Cheng completed her PhD in Neuroscience, Molecular Biology and Genetics from John Hopkins School of Medicine, and completed a fellowship in Clinical Cytogenetics at the University of California, San Francisco. She is board certified by the American Board of Medical Genetics and Genomics in Clinical Cytogenetics, and also holds her New York COQ in Cytogenetics and Oncology Molecular and Cellular Tumor Markers.